Filing Details

Accession Number:
0001277997-12-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-18 14:41:50
Reporting Period:
2012-09-14
Filing Date:
2012-09-18
Accepted Time:
2012-09-18 14:41:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277994 P L Iv Fund Entrepreneurs Venrock C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1277997 P L Iv Associates Venrock C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1305238 Venrock Management Iv, Llc C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1305239 Venrock Partners, L.p. C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1305240 Venrock Partners Management, Llc C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1305243 Vef Management Iv, Llc C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1458177 Venrock Healthcare Capital Partners Lp C/O Venrock
3340 Hillview Ave
Palo Alto CA 94304
No No Yes No
1479354 Vhcp Co-Investment Holdings, Llc C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
1479355 Vhcp Management, Llc C/O Venrock
3340 Hillview Ave.
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-14 35,000 $6.51 3,744,808 No 4 S Indirect By Funds and LLC's
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Funds and LLC's
Footnotes
  1. Consists of 1,721,350 shares held by Venrock Associates IV, L.P. ("VA4"), 351,036 shares held by Venrock Partners, L.P. ("VP"), 42,293 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), 1,361,755 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), 249,101 shares held by VHCP Co-Investment Holdings LLC ("VHCP Co-Invest"), 0 shares held by Venrock Associates V, L.P. ("VA5"), 0 shares held by Venrock Partners V, L.P. ("VP5"), 5,663 shares held by Venrock Management IV, LLC ("VM4"), 1,193 shares held by Venrock Partners Management, LLC ("VPM"), 82 shares held by VEF Managment IV, LLC ("VEFM4") and 12,335 shares held by VHCP Management, LLC ("VHCP Management").
  2. VM4, VPM, VEFM4 are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Bryan Roberts is a member of VM4, VPM, VEFM4, VM5 and VPM5 and a managing member of VHCP Management. Dr. Roberts expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VA5, VP5, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4, VM5, VPM5 and VHCP Management except to the extent of his indirect pecuniary interest therein.